US Stock MarketDetailed Quotes
MEIP MEI Pharma
- 2.7500
- -0.0500-1.79%
Close Oct 2 16:00 ET
18.32MMarket Cap1.03P/E (TTM)
2.8399High2.7500Low13.77KVolume2.7900Open2.8000Pre Close38.46KTurnover0.28%Turnover Ratio1.03P/E (Static)6.66MShares6.909952wk High0.55P/B13.55MFloat Cap2.729352wk Low--Dividend TTM4.93MShs Float12210.9816Historical High--Div YieldTTM3.21%Amplitude2.7293Historical Low2.7920Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
MEI Pharma Stock Forum
NEWS
MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients
MEI Pharma, Inc. reports positive results from the ongoing Phase 1b study of ME-344 in combination with bevacizumab for relapsed metastatic colorectal cancer. 25% of patients had no disease progression at Week 16, exceeding the threshold to add more patients. The combination was well-tolerated, leading to the...
$Gossamer Bio (GOSS.US)$ $Starry Group (STRY.US)$ $Helbiz (HLBZ.US)$ $MEI Pharma (MEIP.US)$ $Digital Brands Group (DBGI.US)$ $Cosmos Health (COSM.US)$ $COMSovereign (COMS.US)$ $Mirati Therapeutics (MRTX.US)$ $United Parcel Service (UPS.US)$ $Sumo Logic (SUMO.US)$
wherr is thr link for earnings
Tomorrow to the 🚀🌕
https://www.etfdailynews.com/2022/05/02/mei-pharma-inc-nasdaqmeip-sees-significant-increase-in-short-interest/
Finally
No comment yet